Researchers, pharmaceutical companies, insurance companies, and other medical entities use health data to enhance healthcare and patient outcomes. NFTs are an exceptional way for individuals to monetize their health data while maintaining privacy.
Our platform’s anonymous format preserves patient privacy as it doesn’t keep personally identifiable information (such as the patient’s name, address, or birthday). In lieu, nonfungible tokens can comprise an individual’s identifier tied to the health data known only to the patient.
An alternative to selling health data NFTs at once is to license them — this option gives greater control to the patients over their data and enables them to gain royalties on future uses.
Aimedis’ Avalon metaverse offers all these possibilities to our users, equipped with a blockchain-based platform that permits patients to set granular permissions on how their health data is used and for which purposes.
Users can also access exclusive benefits and services by utilizing their NFT health data, for example, to gain access to a personalized plan or to join a clinical trial for a new drug. Patients can use our blockchain-based platform to confirm their eligibility for these anonymously.
Nonfungible data monetization is a newly created field that continues to advance every day. Some challenges need to be addressed, as with any recent technology. However, the actual benefits and potential advantages are considerable: it provides patients with more control over their health data, enables the possibility of generating additional income, and advances the quality of care for everyone.
Ana Marques
